Luteolin potentiated TRAIL-induced cytotoxicity, and the combination exhibited markedly reduced Mcl-1, FLIP, STAT3, and Akt levels in the RCC cells when compared to TRAIL alone. The gene discussed is AKT1; the disease is renal cell carcinoma.